Vanguard Business·62d ago
Shareholders of Neimeth International Pharmaceuticals Plc have approved the Board of Directors' plans to raise additional capital aimed at accelerating the company's expansion and completing its pharmaceutical manufacturing facility in Amawbia, Anambra State. This decision was made during the company's 67th Annual General Meeting (AGM), which was held virtually, where shareholders unanimously approved all resolutions proposed by the board.